Lung Cancer: Targets and Therapy
Subject Categories
Subject Areas
Aims & Scope
Abstracting & Indexing
Detailed Metrics
| Total Docs. (latest) | 18 |
| Total Docs. (3 years) | 39 |
| Total Refs. | 911 |
| Total Citations (3 years) | 114 |
| Citable Docs. (3 years) | 23 |
| Citations / Doc. (2 years) | 2.94 |
| Ref. / Doc. | 50.61 |
| % Female | 45.6% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Top 10 Most Cited Articles
Frequently Asked Questions
What is the impact factor of Lung Cancer: Targets and Therapy?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Lung Cancer: Targets and Therapy has an SJR of 1.028 and is ranked Q2.
What is the SJR and quartile of Lung Cancer: Targets and Therapy?
Lung Cancer: Targets and Therapy has an SJR (SCImago Journal Rank) of 1.028 and its best quartile is Q2.
What is the H-index of Lung Cancer: Targets and Therapy?
The H-index of Lung Cancer: Targets and Therapy is 32, meaning 32 of its articles have each been cited at least 32 times.
Is Lung Cancer: Targets and Therapy indexed in Scopus?
Yes. Lung Cancer: Targets and Therapy is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.